Connect with us

Berita

Polres Tanjung Perak Berhasil Gagalkan Peredaran Sabu Sebanyak 40 Kg

Published

on

Surabaya – Kepolisian Resor Polres Pelabuhan Tanjung Perak Surabaya, Polda Jatim, mengungkap sebanyak 250 kasus penyalahgunaan peredaran narkoba selama Januari hingga akhir tahun 2022, yang terjadi di wilayah hukum Polres setempat.

“Selama tahun 2022, kami sudah menangani sebanyak 250 laporan polisi tentang penyalahgunaan narkotika,” kata Kapolres Pelabuhan Tanjung Perak Surabaya, AKBP Anton Elfrino Trisanto melalui Kasat Narkoba AKP Hendro Utaryo di Surabaya.

Menurut dia, dari 250 kasus narkoba tersebut, pihaknya telah menangkap sebanyak 316 orang tersangka guna menjalani proses hukum lebih lanjut.

Adapun barang bukti yang disita petugas mencapai 40,258,41 kilogram sabu-sabu, ganja sebanyak 296,4 gram lebih, pil ekstasi sebanyak 5.002 butir, dan pil dobel L 11.521.415 butir.

Adapun, jumlah kasus narkoba yang ditangani tahun ini naik dibandingkan angka kasus pada tahun 2021. Pada tahun lalu, ada sebanyak 135 kasus narkoba.

“Tahun ini kita ada 250 kasus dengan 316 tersangka. Dari segi kasus, tersangka, dan barang bukti semuanya mengalami peningkatan dibanding tahun lalu,” tutur AKP Hendro.

Ia menambahkan sesuai data, ratusan pengungkapan kasus narkoba itu jaringan internasional barang dari China masuk ke Jakarta, kemudian akan diedarkan ke pulau Jawa termasuk Surabaya.

Seperti diketahui, Berawal terungkapnya peredaran sabu dan pil ekstasi tersebut, dari salah satu pelaku yaitu, Yudi Astono pada saat itu mereka mendapat perintah dari Agus Wahyu Trianto, untuk mengedarkan sabu di kota Surabaya, dengan cara sistem ranjau.

Hendro menyampaikan, pelaku Agus Wahyu Trianto, awalnya menitipkan barang haram sabu dan pil dobel LL dalam jumlah besar itu kepada Tri Juni Farudin.

“Dari pelaku Yudi Astono, yang awalnya kita amankan terlebih dulu selanjutnya anggota melakukan pengembangan kemudian mendapatkan dua identitas yaitu, Agus Wahyu Rianto dan Tri Juni Farudin, lantas petugas bergegas melakukan pengejaran pada pelaku,” jelas Hendro, pada Jum’at (31/12/2022).

Dalam pengejaran di wilayah Tapak Siring Surabaya, anggota kami di lapangan polisi mengamankan Agus Wahyu Rianto, dan saat dilakukan penggeledahan anggota menemukan barang bukti 6,93 kilogram sabu-sabu, serta serbuk pil ekstasi 8,34 dan 10 butir Pil ekstasi.

Hendro menambahkan, tidak berhenti sampai disini kemudian anggota Satnarkoba melakukan penyelidikan, di wilayah Mojokerto, akhirnya pelaku Tri Juni Farudin, diamankan dengan barang bukti yang ditanam oleh pelaku di persawahan sebanyak, 11.300.000 pil dobel LL dan sabu dengan berat, 30,111 kilogram.

Dengan upaya intensif tersebut, dia berharap kasus penyalahgunaan peredaran narkotika di wilayah hukum Polres Pelabuhan Tanjung Perak Surabaya dapat terus berkurang.

“Pada prinsipnya kita terus berupaya memberantas peredaran narkoba dimanapun tempatnya. Mudah-mudahan tahun depan kasusnya bisa berkurang drastis,” pungkasnya.(*)

Continue Reading
Click to comment

Leave a Reply

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

tc-check-test1

Published

on

tc-manager precheck test1 – https://test1.com

Continue Reading

Trending